— Know what they know.
Not Investment Advice

ACTU NASDAQ

Actuate Therapeutics Inc
1W: +20.4% 1M: -37.0% 3M: -41.5% YTD: -86.4% 1Y: -88.2%
$0.82
-0.07 (-7.89%)
 
Weekly Expected Move ±19.2%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $19.6M mcap · 9M float · 3.73% daily turnover · Short 61% of daily vol

Supply Chain Overview

3 relationships
3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2025-03-28
Earliest Filing
2025-11-28
Latest Filing
investor: 2 partner: 1

Counterparties (Filed by ACTU)

3 relationships

Companies named in ACTU's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Craig-Hallum Capital Group LLC — partner Sales Agent for At the Market Issuance Sales Agreement 2025-11-28 View
Lucid Capital Markets, LLC LCID investor Underwriter for the underwritten offering of common stock 2025-09-10 View
B. Riley Principal Capital II, LLC — investor Actuate Therapeutics, Inc. entered into a Common Stock Purchase Agreement to potentially sell up to $50,000,000 of commo 2025-03-28 View
Recent 8-K Filings (18)
Filing Date Description Type SEC
2026-07-17 Delisting Notice View
2026-05-22 Shareholder Vote View
2026-05-06 Officer/Director Change; Other Events; Exhibits View
2026-01-12 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-11-28 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-11-21 Other Events View
2025-09-10 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-06-26 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2025-06-05 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-06-02 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-05-23 Submission of Matters to a Vote of Security Holders View
2025-05-06 Other Events; Financial Statements and Exhibits View
2025-03-28 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2025-02-07 Other Events View
2024-12-17 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-11-12 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-08-19 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2024-08-14 Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms